trending Market Intelligence /marketintelligence/en/news-insights/trending/zef4k0ev4u4abcspneuuog2 content esgSubNav
In This List

NGL Fine-Chem board member resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


NGL Fine-Chem board member resigns

NGL Fine-Chem Ltd. said Dhananjay Mungale resigned as nonexecutive independent director Feb. 23.

The Mumbai, India-based company manufactures drugs for animal health and human health applications.